Denali Therapeutics Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Denali Therapeutics Inc had 387.63M in cash and cash equivalents.

Denali Therapeutics Inc reported 131.09M in total liabilities as of the latest reported quarter, including 98.35M in current liabilities and 32.74M in non-current liabilities.

As of the latest reported quarter, Denali Therapeutics Inc's total assets were 1.14B, consisting of 900.66M in current assets and 244.20M in non-current assets.

Denali Therapeutics Inc reported 1.01B in total shareholders' equity as of the latest reported quarter.